13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001892770
Total reported value
$189.2M
$189.2M
92 檔
78.6%
In Q3 2024, Knott David M Jr's U.S. equity holdings reached a combined market value of $189.2M, distributed across 92 disclosed stock positions.
During Q3 2024, Knott David M Jr's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including CLMT, APO, GOOG) accounted for 78.6% of total reported equity market value during Q3 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CLMT | Calumet Inc | Stock-Other | 30.36% | — | — | |
| 2 | APO | Apollo Global Management Inc | Stock-Financials | 11.07% | -0.85% | — | |
| 3 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 7.39% | +1.46% | — | |
| 4 | CLOZ | Eldridge Bbb-b Clo ETF | ETF-Other | 5.75% | -0.06% | — | |
| 5 | DCGO | Docgo Inc | Stock-Other | 4.02% | -0.27% | — | |
| 6 | PFE | Pfizer Inc | Stock-Healthcare | 2.56% | -0.13% | -9.73% | |
| 7 | MFCSF | Medical Facilities CORP | Stock-Other | 2.10% | — | — | |
| 8 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 2.04% | — | -11.33% | |
| 9 | OABI | Omniab Inc | Stock-Other | 1.91% | — | +2.68% | |
| 10 | ICLO | Invesco Aaa Clo F/r Note ETF | ETF-Other | 1.91% | — | -20.55% | |
| 11 | ARDX | Ardelyx Inc | Stock-Other | 1.85% | -0.03% | -11.64% | |
| 12 | JPM | Jpmorgan Chase & Co | Stock-Financials | 1.74% | -0.28% | — | |
| 13 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 1.72% | — | -0.30% | |
| 14 | JAAA | Janus Henderson Aaa Clo ETF | ETF-Other | 1.70% | -0.30% | +58.86% | |
| 15 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 1.66% | -1.77% | EXIT | |
| 16 | TVTX | Travere Therapeutics Inc | Stock-Other | 1.42% | +1.93% | -2.91% | |
| 17 | ✓ | Inozyme Pharma Inc | Stock-Other | 1.16% | — | — | |
| 18 | BCRX | Biocryst Pharmaceuticals Inc | Stock-Other | 1.14% | — | +21.54% | |
| 19 | XERS | Xeris Biopharma Holdings Inc | Stock-Other | 1.12% | +0.78% | +21.95% | |
| 20 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 1.05% | — | — | |
| 21 | IMVT | Immunovant Inc | Stock-Other | 1.03% | — | +0.55% | |
| 22 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 0.97% | — | -48.66% | |
| 23 | CSX | Csx CORP | Stock-Industrials | 0.95% | — | — | |
| 24 | ESGRP | Enstar Group Limited - Deposita | Stock-Other | 0.95% | — | — | |
| 25 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 0.94% | — | — | |
| 26 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 0.93% | +0.13% | — | |
| 27 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 0.93% | -0.82% | +17.64% | |
| 28 | DMRC | Digimarc Corporation | Stock-Other | 0.88% | — | — | |
| 29 | AB | Alliancebernstein Holding LP | Stock-Other | 0.66% | -0.18% | -2.04% | |
| 30 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.54% | -0.06% | EXIT | |
| 31 | RHP | Ryman Hospitality Properties | Stock-Real Estate | 0.51% | +0.03% | — | |
| 32 | ABBV | Abbvie Inc | Stock-Healthcare | 0.39% | — | — | |
| 33 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 0.39% | +0.11% | -28.57% | |
| 34 | EOLS | Evolus Inc | Stock-Other | 0.37% | -0.24% | EXIT | |
| 35 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 0.37% | — | -33.33% | |
| 36 | 6D8 | Dupont De Nemours Inc | Stock-Other | 0.35% | -0.10% | EXIT | |
| 37 | KMB | Kimberly-clark CORP | Stock-Consumer Staples | 0.34% | — | — | |
| 38 | IRWD | Ironwood Pharmaceuticals Inc | Stock-Other | 0.34% | — | -44.05% | |
| 39 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 0.32% | — | — | |
| 40 | LXRX | Lexicon Pharmaceuticals Inc | Stock-Other | 0.31% | — | — | |
| 41 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 0.28% | — | -2.25% | |
| 42 | MSFT | Microsoft CORP | Stock-Tech | 0.27% | -0.03% | — | |
| 43 | CTVA | Corteva Inc | Stock-Materials | 0.27% | -0.01% | — | |
| 44 | MDLZ | Mondelez International Inc-a | Stock-Consumer Staples | 0.26% | -0.01% | -35.71% | |
| 45 | AAPL | Apple Inc | Stock-Tech | 0.23% | — | — | |
| 46 | ZIMV | Zimvie Inc | Stock-Other | 0.22% | — | — | |
| 47 | CNQ | Canadian Natural Resources | Stock-Energy | 0.22% | -0.14% | — | |
| 48 | XOMA | Xoma Royalty Corporation | Stock-Other | 0.21% | — | — | |
| 49 | CLOX | Eldridge Aaa Clo ETF | ETF-Other | 0.20% | — | — | |
| 50 | IBM | Intl Business Machines CORP | Stock-Tech | 0.19% | +0.01% | — |
According to official SEC Form 13F filings, Knott David M Jr reported a total U.S. public equity portfolio value of $189.2M across 92 disclosed positions in Q3 2024.
During Q3 2024, Knott David M Jr's top holdings by market value included CLMT (30.4%)、APO (11.1%)、GOOG (7.4%). The largest single position, CLMT, represented 30.4% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In Q3 2024, Knott David M Jr made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.